Recall archive / FDA drug enforcement
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. ... — FDA record D-0366-2024
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Feb 20, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
- Reason
- Failed Dissolution Specifications
- Classification
- Class II
- Recalling firm
- Eugia US LLC
- Quantity
- 10,080 vials
- Agency-reported status
- Ongoing
- Source record identifier
- D-0366-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
OH, TN, LA, MS
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Mar 13, 2024
- Recall initiation date
- Feb 20, 2024
- Center classification date
- Mar 4, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.